pediatrics brain cancer
Showing 1 - 25 of >10,000
Pediatric Brain Tumor Trial in Boston (HIIT Exercise Program, Control Group)
Not yet recruiting
- Pediatric Brain Tumor
- HIIT Exercise Program
- Control Group
-
Boston, MassachusettsDana Farber Cancer Institute
Feb 13, 2023
Urinary Incontinence, Daytime Wetting, Urination Disorders Trial in Denmark (Sacral TENS)
Recruiting
- Urinary Incontinence
- +9 more
- Sacral TENS
-
Aalborg, Denmark
- +3 more
Aug 4, 2023
Severe Traumatic Brain Injury Trial in Worldwide (ICP, CREVICE)
Not yet recruiting
- Severe Traumatic Brain Injury
- ICP
- CREVICE
-
Seattle, Washington
- +8 more
Oct 1, 2022
Craniocerebral Trauma, Pediatrics Trial in France (usual care, S100B)
Completed
- Craniocerebral Trauma
- Pediatrics
- usual care
- S100B
-
Bron, France
- +10 more
Jan 4, 2023
Real World Evidence on the Use of Medical Cannabis in Pediatrics
Not yet recruiting
- Cancer
- +2 more
- Medical Cannabis
- (no location specified)
May 8, 2023
Breast Cancer, Brain Metastases Trial in New York (Brain Imaging with 18F-FES)
Not yet recruiting
- Breast Cancer
- Brain Metastases
- Brain Imaging with 18F-FES
-
New York, New YorkNew York-Presbyterian/Weill Cornell Medical Center
Oct 2, 2023
Breast Cancer With Brain Metastases Trial in Wuhan (pyrotinib+capecitabine+bevacizumab)
Recruiting
- Breast Cancer With Brain Metastases
-
Wuhan, Hubei, ChinaTongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 22, 2023
Breast Cancer, Brain Metastases, Radiotherapy Trial in Shanghai (Combination use of SRT with T-DXd)
Not yet recruiting
- Breast Cancer
- +2 more
- Combination use of SRT with T-DXd
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 14, 2023
Ependymoma, Medulloblastoma, Glioblastoma Trial in Augusta (Ibrutinib, Indoximod, Cyclophosphamide)
Recruiting
- Ependymoma
- +3 more
- Ibrutinib
- +3 more
-
Augusta, GeorgiaAugusta University, Georgia Cancer Center
Dec 16, 2022
Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Shanghai (Pyrotinib Plus Capecitabine combined with brain
Active, not recruiting
- Breast Cancer
- +2 more
- Pyrotinib Plus Capecitabine combined with brain radiotherapy
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 14, 2023
Breast Cancer Brain Metastases Trial in Guangzhou (SPH4336 Tablets)
Not yet recruiting
- Breast Cancer Brain Metastases
- SPH4336 Tablets
-
Guangzhou, Guangdong, ChinaAffiliated Cancer Hospital, Sun Yat-sen University
May 24, 2023
Brain Cancer, Glioblastoma, Metastatic Cancer Trial in New York (Trastuzumab deruxtecan)
Recruiting
- Brain Cancer
- +4 more
- Trastuzumab deruxtecan
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 22, 2023
Breast Cancer Trial in Xi'an (Disitamab Vedotin plus pyrotinib or naratinib)
Not yet recruiting
- Breast Cancer
- Disitamab Vedotin plus pyrotinib or naratinib
-
Xi'an, Shaanxi, ChinaXi'an International Medical Center Hospital
Aug 27, 2023
Hypoxic-Ischemic Encephalopathy, Asphyxia, Hypotension Trial in Budapest (Hydrocortisone)
Recruiting
- Hypoxic-Ischemic Encephalopathy
- +3 more
-
Budapest, Pest Megye, HungarySemmelweis University Department of Pediatrics (Bókay street Uni
Apr 19, 2023
Brain Metastases, Nonsmall Cell Lung Cancer Stage III Trial in Winston-Salem (MRI of the Brain, Blood draws, Quality of Life
Not yet recruiting
- Brain Metastases
- Nonsmall Cell Lung Cancer Stage III
- MRI of the Brain
- +2 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Cente
Jan 19, 2023
NSCLC, EGFR Activating Mutation, Brain Metastases Trial in Beijing (TY-9591, Osimertinib)
Not yet recruiting
- NSCLC
- +2 more
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospitial,Chinese Academy of Medic
Jul 9, 2023
Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)
Not yet recruiting
- Lung Cancer
- +2 more
- Alectinib
- Stereotactic Radiosurgery
- (no location specified)
Aug 4, 2023
Metastatic Breast Cancer Trial in Zhengzhou (SHR-A1811, Pyrotinib, Bevacizumab)
Not yet recruiting
- Metastatic Breast Cancer
- SHR-A1811
- +2 more
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Mar 13, 2023
Breast Cancer Trial in Xi'an (Inetetamab plus pyrotiniband and capecitabine)
Active, not recruiting
- Breast Cancer
- Inetetamab plus pyrotiniband and capecitabine
-
Xi'an, Shaanxi, ChinaXi'an International Medical Center Hospital
Aug 27, 2023
Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))
Not yet recruiting
- Breast Cancer
- Metastatic Breast Cancer
- Trastuzumab-Deruxtecan (T-DXd)
- (no location specified)
Sep 20, 2023
Breast Cancer Stage IV Trial in Vienna (Datopotamab deruxtecan)
Recruiting
- Breast Cancer Stage IV
- Datopotamab deruxtecan
-
Vienna, AustriaAKH Universitaetsklinikum Vienna, Department f. Internal medicin
May 19, 2023
Compensation to Maintain Cognitive Function in Adults Newly
Completed
- Primary Brain Tumor
- Brain Metastases, Adult
- Neuropsychological Testing
-
Durham, North CarolinaDuke University Medical Center
Jan 19, 2023
Non Small Cell Lung Cancer Metastatic Trial (MRI)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- MRI
- (no location specified)
May 16, 2023
Brain Cancer, Cognitive Impairment Trial (ImPACT program)
Not yet recruiting
- Brain Cancer
- Cognitive Impairment
- ImPACT program
- (no location specified)
May 11, 2023
European Prospective Investigation Into Childhood Cancer
Not yet recruiting
- Establish Biobanking Initiative Among Southern European Children and Adolescents With Acute Lymphoblastic Leukemia and Favorable Biology Brain Tumors
- Observational
- (no location specified)
May 11, 2022